AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$38.48 USD
+0.95 (2.53%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $38.50 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
AnaptysBio, Inc. [ANAB]
Reports for Purchase
Showing records 1 - 20 ( 164 total )
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Equity Raise at a Premium Signifies Confidence From Investors and Sanofi
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
2Q24 Recap: ANB032 Topline Data Guided to Dec 2024; Rosnilimab Phase 2 Timelines Accelerate
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Checkpoint Agonists With Best-in-Class Potential in Immunology; Initiating at Buy and $55 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Upgrade to OUTPERFORM; Under Peresolimab?s Um-br-ella
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Rosnilimab RD Event Recap - Going for the Gut with UC
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Status Update on the Twins'' Battle Against GPP
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D